News

PMCPA News

Press releases appear below, filter by date.

Grunenthal Ltd and Vifor Pharma UK Limited named in advertisements for breaches of the ABPI Code of Practice

Grünenthal Ltd and Vifor Pharma UK Limited have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press. In addition, Grünenthal has been publicly reprimanded. 

Press release: 06 July 2012
ABPI Code of Practice for the Pharmaceutical Industry Second 2012 Edition
The ABPI Code of Practice for the Pharmaceutical Industry Second 2012 Edition is available to download from the PMCPA website.

Press release: 27 July 2012
PMCPA seeks new independent members to the Code of Practice Appeal Board
Due to retirements the PMCPA is advertising for two new independent members to join the Code of Practice Appeal Board.
Press release: 11 September 2012
PMCPA updates e-learning module for health professionals and quick guides to the Code

Published updates reflect the Second 2012 Edition of the Code.

Following recent changes to the ABPI Code of Practice for the Pharmaceutical Industry, the PMCPA has updated its popular e-learning module and quick guides to the Code.

Press release: 08 October 2012
Merz Pharma, Lilly and Daiichi-Sankyo named in advertisements for breaches of the ABPI Code of Practice

Merz Pharma, Lilly and Daiichi-Sankyo have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.

Press release: 30 November 2012
Bayer HealthCare named in advertisements for breaches of the ABPI Code of Practice

Bayer HealthCare has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.

Press release: 09 December 2012
Amendment of the Code of Practice for the Pharmaceutical Industry

Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry were agreed at an Extraordinary General Meeting of the ABPI on Monday 11 June.

Press release: 15 December 2012
Chiesi Ltd and Vifor Pharma UK Limited named in advertisements for breaches of the ABPI Code of Practice.

Chiesi Ltd and Vifor Pharma UK Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, Chiesi was publicly reprimanded.

Press release: 22 March 2013
Changes to Clause 16.3 (Representatives Examinations) of the Second 2012 Edition of the ABPI Code, have been agreed

The amended text is available on the PMCPA website

Press release: 26 April 2013
Shire Pharmaceuticals Ltd and Roche Products Limited named in advertisements for breaches of the ABPI Code of Practice

Shire Pharmaceuticals Ltd and Roche Products Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.

Press release: 24 May 2013
Gedeon Richter (UK) Ltd has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon,

Gedeon Richter (UK) Ltd has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.

Press release: 06 September 2013
Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry and the PMCPA Constitution and Procedure were agreed at the Half Yearly General Meeting of the ABPI on 5 November

​The amendments result from the new EFPIA Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations and changes to the EFPIA Code on the Promotion of Prescription-Only Medicines to, and Interactions with, Healthcare Professionals. Other amendments to the ABPI Code and the PMCPA Constitution and Procedure were also agreed.

Press release: 06 November 2013
About 154 result(s)